SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The… Read more
SMS Pharmaceuticals Limited (SMSPHARMA) - Total Assets
Latest total assets as of September 2025: ₹12.76 Billion INR
Based on the latest financial reports, SMS Pharmaceuticals Limited (SMSPHARMA) holds total assets worth ₹12.76 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SMS Pharmaceuticals Limited - Total Assets Trend (2005–2025)
This chart illustrates how SMS Pharmaceuticals Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SMS Pharmaceuticals Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
SMS Pharmaceuticals Limited's total assets of ₹12.76 Billion consist of 48.1% current assets and 51.9% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 3.6% |
| Accounts Receivable | ₹2.03 Billion | 17.6% |
| Inventory | ₹2.85 Billion | 24.7% |
| Property, Plant & Equipment | ₹5.66 Billion | 49.1% |
| Intangible Assets | ₹21.30 Million | 0.2% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how SMS Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SMS Pharmaceuticals Limited's current assets represent 48.1% of total assets in 2025, a decrease from 53.6% in 2005.
- Cash Position: Cash and equivalents constituted 3.6% of total assets in 2025, up from 2.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is property, plant & equipment at 49.1% of total assets.
SMS Pharmaceuticals Limited Competitors by Total Assets
Key competitors of SMS Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
PINK:NVSEF
|
USA | $115.49 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
SMS Pharmaceuticals Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - SMS Pharmaceuticals Limited generates 0.68x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, SMS Pharmaceuticals Limited generates $6.00 in net profit.
SMS Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.76 | 1.55 | 1.37 |
| Quick Ratio | 0.92 | 0.71 | 0.57 |
| Cash Ratio | 0.27 | 0.02 | 0.00 |
| Working Capital | ₹2.86 Billion | ₹ 2.07 Billion | ₹ 664.39 Million |
SMS Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between SMS Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.31 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 11.5% |
| Total Assets | ₹11.53 Billion |
| Market Capitalization | $105.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values SMS Pharmaceuticals Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SMS Pharmaceuticals Limited's assets grew by 11.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SMS Pharmaceuticals Limited (2005–2025)
The table below shows the annual total assets of SMS Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹11.53 Billion | +11.47% |
| 2024-03-31 | ₹10.34 Billion | +17.56% |
| 2023-03-31 | ₹8.80 Billion | +2.34% |
| 2022-03-31 | ₹8.60 Billion | +5.82% |
| 2021-03-31 | ₹8.12 Billion | +33.61% |
| 2020-03-31 | ₹6.08 Billion | +8.79% |
| 2019-03-31 | ₹5.59 Billion | +11.20% |
| 2018-03-31 | ₹5.03 Billion | -27.52% |
| 2017-03-31 | ₹6.93 Billion | +5.75% |
| 2016-03-31 | ₹6.56 Billion | +21.13% |
| 2015-03-31 | ₹5.41 Billion | +6.27% |
| 2014-03-31 | ₹5.09 Billion | +8.05% |
| 2013-03-31 | ₹4.71 Billion | -4.16% |
| 2012-03-31 | ₹4.92 Billion | +3.95% |
| 2011-03-31 | ₹4.73 Billion | +8.69% |
| 2010-03-31 | ₹4.35 Billion | +9.26% |
| 2009-03-31 | ₹3.98 Billion | +13.75% |
| 2008-03-31 | ₹3.50 Billion | +17.88% |
| 2007-03-31 | ₹2.97 Billion | +78.94% |
| 2006-03-31 | ₹1.66 Billion | +8.00% |
| 2005-03-31 | ₹1.54 Billion | -- |